DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,943,797 | +19.7% | 15,896 | +15.8% | 0.26% | +12.8% |
| Q2 2023 | $3,294,240 | -3.6% | 13,726 | +1.3% | 0.23% | -22.6% |
| Q1 2023 | $3,416,150 | +94793.1% | 13,554 | -0.1% | 0.29% | -7.0% |
| Q4 2022 | $3,600 | -99.9% | 13,565 | +1.7% | 0.31% | -11.8% |
| Q3 2022 | $3,446,000 | +3.8% | 13,341 | +1.9% | 0.36% | +1.7% |
| Q2 2022 | $3,319,000 | -35.9% | 13,093 | -25.9% | 0.35% | +117.4% |
| Q1 2022 | $5,181,000 | -23.9% | 17,663 | -14.7% | 0.16% | -20.7% |
| Q4 2021 | $6,812,000 | -77.3% | 20,703 | -79.0% | 0.20% | -53.8% |
| Q3 2021 | $29,960,000 | +13.5% | 98,410 | +0.0% | 0.44% | -18.7% |
| Q2 2021 | $26,397,000 | +18.6% | 98,363 | -0.5% | 0.54% | +2.1% |
| Q1 2021 | $22,248,000 | +0.8% | 98,841 | -0.6% | 0.53% | -6.5% |
| Q4 2020 | $22,081,000 | -18.4% | 99,401 | -20.9% | 0.57% | -31.9% |
| Q3 2020 | $27,046,000 | +21.8% | 125,601 | -0.0% | 0.83% | +19.7% |
| Q2 2020 | $22,214,000 | -36.0% | 125,621 | -49.9% | 0.69% | +13.4% |
| Q1 2020 | $34,702,000 | +79.1% | 250,714 | +98.6% | 0.61% | +18.8% |
| Q4 2019 | $19,375,000 | +6.2% | 126,237 | -0.1% | 0.52% | +0.4% |
| Q3 2019 | $18,243,000 | +1.1% | 126,312 | 0.0% | 0.51% | +0.2% |
| Q2 2019 | $18,052,000 | -11.5% | 126,312 | -18.2% | 0.51% | -8.7% |
| Q1 2019 | $20,394,000 | +28.1% | 154,477 | +0.1% | 0.56% | +23.8% |
| Q4 2018 | $15,920,000 | -4.9% | 154,386 | +0.3% | 0.45% | +6.6% |
| Q3 2018 | $16,733,000 | +1695.4% | 153,990 | +1529.5% | 0.42% | +865.9% |
| Q2 2018 | $932,000 | +0.6% | 9,450 | 0.0% | 0.04% | -6.4% |
| Q1 2018 | $926,000 | +3.3% | 9,450 | -2.1% | 0.05% | +11.9% |
| Q4 2017 | $896,000 | +8.2% | 9,650 | 0.0% | 0.04% | +2.4% |
| Q3 2017 | $828,000 | -17.2% | 9,650 | -18.6% | 0.04% | -16.3% |
| Q2 2017 | $1,000,000 | -1.4% | 11,850 | 0.0% | 0.05% | -2.0% |
| Q1 2017 | $1,014,000 | -5.9% | 11,850 | -14.4% | 0.05% | -2.0% |
| Q4 2016 | $1,078,000 | -0.7% | 13,850 | 0.0% | 0.05% | -15.0% |
| Q3 2016 | $1,086,000 | -21.6% | 13,850 | +0.9% | 0.06% | -24.1% |
| Q2 2016 | $1,386,000 | +6.7% | 13,720 | +0.1% | 0.08% | -6.0% |
| Q1 2016 | $1,299,000 | +4.1% | 13,700 | +1.9% | 0.08% | -10.6% |
| Q4 2015 | $1,248,000 | +8.9% | 13,440 | 0.0% | 0.09% | +8.0% |
| Q3 2015 | $1,146,000 | -0.3% | 13,440 | +0.1% | 0.09% | +1.2% |
| Q2 2015 | $1,149,000 | +0.7% | 13,430 | 0.0% | 0.09% | -2.3% |
| Q1 2015 | $1,141,000 | +6.7% | 13,430 | +7.7% | 0.09% | +22.2% |
| Q4 2014 | $1,069,000 | +24.2% | 12,470 | +10.0% | 0.07% | +22.0% |
| Q3 2014 | $861,000 | -3.9% | 11,335 | -0.4% | 0.06% | -1.7% |
| Q2 2014 | $896,000 | +5.0% | 11,375 | 0.0% | 0.06% | +3.4% |
| Q1 2014 | $853,000 | -2.8% | 11,375 | 0.0% | 0.06% | -3.3% |
| Q4 2013 | $878,000 | -2.8% | 11,375 | -12.6% | 0.06% | -15.5% |
| Q3 2013 | $903,000 | +4.3% | 13,020 | -4.9% | 0.07% | +4.4% |
| Q2 2013 | $866,000 | – | 13,685 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |